STOCK TITAN

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will deliver a presentation at the 43rd Annual J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 10:30 a.m. PST. Interested parties can access a live webcast of the presentation through Bio-Techne's Investor Relations website's IR Calendar page.

Loading...
Loading translation...
Argus Session date unavailable
+2.49% session move Open Argus
Details

News Market Reaction – TECH

The recorded move for TECH in the trading session of this news was +2.49%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 10:30 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne 
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:  David Clair, Vice President, Investor Relations & Corporate Development  
               david.clair@bio-techne.com 
               612-656-4416  

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302335119.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bio-Techne (TECH) present at the 2025 J.P. Morgan Healthcare Conference?

Bio-Techne will present at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 10:30 a.m. PST.

How can investors watch Bio-Techne's (TECH) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via a live webcast accessible through Bio-Techne's Investor Relations website at the IR Calendar page.

Who will represent Bio-Techne (TECH) at the 2025 J.P. Morgan Healthcare Conference?

Kim Kelderman, President and Chief Executive Officer of Bio-Techne, will represent the company at the conference.

Which annual J.P. Morgan Healthcare Conference will Bio-Techne (TECH) attend in 2025?

Bio-Techne will attend the 43rd Annual J.P. Morgan Healthcare Conference in 2025.

Keep reading